EE516 Healthcare Resource Utilization and Time Burden in Patients With Myelodysplastic Syndromes/Neoplasms Initiating Oral Decitabine and Cedazuridine or Intravenous/Subcutaneous Hypomethylating Agents
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.898
https://www.valueinhealthjournal.com/article/S1098-3015(25)03455-2/fulltext
Title :
EE516 Healthcare Resource Utilization and Time Burden in Patients With Myelodysplastic Syndromes/Neoplasms Initiating Oral Decitabine and Cedazuridine or Intravenous/Subcutaneous Hypomethylating Agents
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)03455-2&doi=10.1016/j.jval.2025.09.898
First page :
Section Title :
Open access? :
No
Section Order :
10450